Healthcare Industry News: Smiths Medical
News Release - January 4, 2006
Smiths Medical MD Receives FDA Clearance on Infusion Pump for Micro InfusionsST. PAUL, Minn.--(HSMN NewsFeed)--Jan. 4, 2006--Smiths Medical MD, Inc. announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new CADD-MS(TM) 3 Ambulatory Infusion Pump for micro infusion therapies.
Based on the successful Deltec Cozmo® insulin pump platform, the small, lightweight CADD-MS(TM) 3 ambulatory infusion pump features multiple programming options for a broad application of micro infusion therapies, security pass codes for set up and programming, and programming menus that are easy to use and easy to follow.
The CADD-MS(TM) 3 pump is indicated for IV, subcutaneous, epidural and intrathecal routes of delivery for therapies requiring small doses of medication.
The addition of the CADD-MS(TM) 3 infusion pump to Smiths Medical's existing product line builds on the strong leadership of the CADD® ambulatory infusion pumps and is the first of several new products designed specifically to address the home infusion market.
Smiths Medical MD, Inc. is a world leader in the design, manufacture, and distribution of medical devices used in infusion therapy, including CADD® ambulatory infusion pumps, PORT-A-CATH® implantable access systems, GRIPPER PLUS® safety huber needles, CliniCath® PICC infusion catheters, and the CozMore® insulin technology system. Headquartered in St. Paul, Minnesota, Smiths Medical MD (Medication Delivery) is part of Smiths Group, London, and is committed to developing the highest quality, most reliable products to provide innovative, convenient and cost-effective drug delivery worldwide. For more information, visit www.smiths-medical.com or call 1-800-426-2448.
Source: Smiths Medical MD
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.